Tema ETFs’s AnaptysBio ANAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.68M Buy
33,414
+2,144
+7% +$121K 0.06% 211
2026
Q2
$2.11M Buy
31,270
+201
+0.6% +$12.2K 0.07% 180
2026
Q1
$1.72M Buy
31,069
+8,509
+38% +$458K 0.12% 163
2025
Q4
$1.09M Buy
22,560
+11,585
+106% +$452K 0.08% 225
2025
Q3
$336K Sell
10,975
-429
-4% -$9.8K 0.03% 444
2025
Q2
$253K Buy
+11,404
New +$239K 0.07% 155

Other funds holding ANAB

Tema ETFs's ANAB Position: Q3 2026 in Review

Tema ETFs increased its AnaptysBio (ANAB) stake by 6.9% in Q3 2026, buying an estimated $121K and bringing the position to 33,414 shares worth $1.68M. The position accounts for 0.06% of the portfolio, ranked #211.

Tema ETFs first reported a position in ANAB in Q2 2025 and has held it in 6 quarters since. The position peaked at $2.11M in Q2 2026. 14 funds tracked by Wall St. Rank hold ANAB as of Q3 2026.

  • Tema ETFs held 33,414 shares of AnaptysBio worth $1.68M as of Q3 2026.
  • Tema ETFs bought 2,144 AnaptysBio shares in Q3 2026, an estimated $121K.
  • AnaptysBio made up 0.06% of Tema ETFs's portfolio in Q3 2026, its #211 holding.
  • Tema ETFs first reported a position in AnaptysBio in Q2 2025 and has held it in 6 quarters since.
  • Tema ETFs's AnaptysBio position peaked at $2.11M in Q2 2026.
  • 14 funds tracked by Wall St. Rank held AnaptysBio as of Q3 2026.

Based on Tema ETFs's 13F filing for Q3 2026, filed 16 Oct 2026.